These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32128695)

  • 1. HPRT-related hyperuricemia with a novel p.V35M mutation in HPRT1 presenting familial juvenile gout.
    Mishima E; Mori T; Nakajima Y; Toyohara T; Kikuchi K; Oikawa Y; Matsuhashi T; Maeda Y; Suzuki T; Kudo M; Ito S; Sohara E; Uchida S; Abe T
    CEN Case Rep; 2020 Aug; 9(3):210-214. PubMed ID: 32128695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial HPRT Deficiency with a Novel Mutation of the HPRT Gene in Combination with Four Previously Reported Variants Associated with Hyperuricemia.
    Kurajoh M; Koyama H; Hatayama M; Okazaki H; Shoji T; Moriwaki Y; Yamamoto T; Nakayama T; Namba M
    Intern Med; 2015; 54(12):1523-6. PubMed ID: 26073243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperuricemia and gout due to deficiency of hypoxanthine-guanine phosphoribosyltransferase in female carriers: New insight to differential diagnosis.
    Kostalova E; Pavelka K; Vlaskova H; Musalkova D; Stiburkova B
    Clin Chim Acta; 2015 Feb; 440():214-7. PubMed ID: 25476133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eighteen-year follow-up of a patient with partial hypoxanthine phosphoribosyltransferase deficiency and a new mutation.
    Gregoric A; Rabelink GM; Kokalj Vokac N; Varda NM; Zagradisnik B
    Pediatr Nephrol; 2005 Sep; 20(9):1346-8. PubMed ID: 15965771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Deficiencies of hypoxanthine guanine phosphoribosyltransferase (HPRT)].
    Yamada Y
    Nihon Rinsho; 2008 Apr; 66(4):687-93. PubMed ID: 18409516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kelley-Seegmiller syndrome in a patient with complete hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Cossu A; Micheli V; Jacomelli G; Carcassi A
    Clin Exp Rheumatol; 2002; 20(6):851-3. PubMed ID: 12508781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unapparent hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Torres RJ; Puente S; Menendez A; Fernandez-Garcia N
    Clin Chim Acta; 2017 Sep; 472():136-138. PubMed ID: 28782500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of rasburicase in hyperuricemia secondary to Lesch-Nyhan syndrome.
    Roche A; Pérez-Dueñas B; Camacho JA; Torres RJ; Puig JG; García-Cazorla A; Artuch R
    Am J Kidney Dis; 2009 Apr; 53(4):677-80. PubMed ID: 18992978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome.
    Torres RJ; Puig JG
    Orphanet J Rare Dis; 2007 Dec; 2():48. PubMed ID: 18067674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of HPRT deficiencies: an update of the spectrum of Asian mutations with novel mutations.
    Yamada Y; Nomura N; Yamada K; Wakamatsu N
    Mol Genet Metab; 2007 Jan; 90(1):70-6. PubMed ID: 17027311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late diagnosis of Lesch-Nyhan disease variant.
    Doucet BP; Jegatheesan D; Burke J
    BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24326440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPRTSardinia: a new point mutation causing HPRT deficiency without Lesch-Nyhan disease.
    Cossu A; Orrù S; Jacomelli G; Carcassi C; Contu L; Sestini S; Corradi MR; Pompucci G; Carcassi A; Micheli V
    Biochim Biophys Acta; 2006 Jan; 1762(1):29-33. PubMed ID: 16216473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the phenotypic spectrum of Lesch-Nyhan disease and its attenuated variants.
    Torres RJ; Puig JG; Jinnah HA
    Curr Rheumatol Rep; 2012 Apr; 14(2):189-94. PubMed ID: 22198833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia.
    Xu S; Liu X; Ming J; Chen S; Wang Y; Liu X; Liu H; Peng Y; Wang J; Lin J; Ji H; Liu B; Lu Y; Liu P; Zhang Y; Ji Q
    Int J Rheum Dis; 2015 Jul; 18(6):669-78. PubMed ID: 26013187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal HPRT coding region in a male with gout due to HPRT deficiency.
    Dawson PA; Gordon RB; Keough DT; Emmerson BT
    Mol Genet Metab; 2005 May; 85(1):78-80. PubMed ID: 15862284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiencies: novel mutations and the spectrum of Japanese mutations.
    Yamada Y; Nomura N; Yamada K; Wakamatsu N; Kaneko K; Fujimori S
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):570-4. PubMed ID: 18600506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPRT deficiency in a two-month-old child presenting acute renal failure and gout with a new deletion of two bases in exon 3 of the HPRT gene.
    Zamora A; Escárcega RO; Vazquez R; Zamora A; O'Neill JP
    Arch Med Res; 2007 May; 38(4):460-2. PubMed ID: 17416296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febuxostat for the chronic management of hyperuricemia in patients with gout.
    Chinchilla SP; Urionaguena I; Perez-Ruiz F
    Expert Rev Clin Pharmacol; 2016; 9(5):665-73. PubMed ID: 26942273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complete and partial deficiencies of hypoxanthine guanine phosphoribosyltransferase (HPRT)].
    Yamada Y
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():288-93. PubMed ID: 12629733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.